Project Manager, Discovery

Position Summary

We are seeking an exceptional Project Manager, who will play a critical role in coordinating and managing discovery projects to support R&D.

The successful candidate should have extensive experience in project management, a proven ability to deliver results in a fast-paced environment, and the ability to coordinate cross-functional teams including synthetic and analytical chemistry, CMC, pharmacology, toxicology, and clinical. Candidates should have a general familiarity with the drug development process and experience with in vitro and/or in vivo studies to support candidate nomination in pharma/biotech or a CRO. Excellent communication, interpersonal, and organizational skills, and the ability to work in a dynamic environment will be critical to success.

Key Roles & Responsibilities

• Support the planning and execution of high impact R&D projects from early-stage discovery through candidate nomination.
• Create and manage detailed plans that account for various aspects of drug discovery as well as managing the budget, resource allocation and risk management strategies.
• Monitor project progress and measure project performance to identify areas for improvement.
• Recommend/make adjustments as needed to ensure progress timeline and goal achievement.
• Proactively identify potential project risks and develop with the team comprehensive mitigation plans to overcome obstacles and ensure project success.
• Serve as the main point of contact for all project-related communications, fostering strong relationship with internal teams, and external partners.
• Facilitate project meetings, prepare minutes for select meetings, and track action items
• Facilitate effective collaboration across R&D functional teams, ensuring alignment on project goals and priorities.
• Provide project updates on a consistent basis to various stakeholders, including the leadership team, about strategy, adjustments, and development progress.
• Develop and manage in partnership with Finance project budget, detailed forecasting and reporting, with a keen focus on cost control and resource optimization, balancing project needs and organizational capacity.

Job Requirements

• Bachelor’s degree in a life science, project management, or business discipline is required
• At least 8 years of biotech, pharmaceutical, or life sciences project management experience including leadership experience.
• Experience in drug development is required, with endocrine and/or rare disease experience preferred
• Demonstrated understanding of the drug discovery/development process including key disciplines of CMC, pharmacology, toxicology, and clinical.
• Project management and analytical skills, including strong organization, prioritization, and problem-solving skills.
• Demonstrated ability to deliver results with high quality, on time, and within budget.
• Strong oral, verbal, and interpersonal communication skills with a bias toward action.
• Willingness and ability to build and maintain strong, cross-functional relationships within all levels of the department and throughout the organization.
• Project management professional (PMP) certification preferred.
• Proficiency in the use of project management tools and techniques (e.g., MS Project, MS Excel, MS PowerPoint, etc . . .).

Company Overview:

MBX Biosciences, Inc. (NASDAQ: MBX) is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The Company was founded by global leaders with a transformative approach to peptide drug design and development. Leveraging this expertise, the Company designed its proprietary Precision Endocrine Peptide™ (PEP™) platform to overcome the key limitations of unmodified and modified peptide therapies and to improve clinical outcomes and simplify disease management for patients. PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company’s pipeline includes its lead product candidate MBX 2109, in Phase 2 development for the treatment of chronic hypoparathyroidism (HP); MBX 1416, in Phase 1 development for the treatment of post-bariatric hypoglycemia (PBH); and an obesity portfolio that includes MBX 4291, as well as multiple discovery and pre-clinical candidates in development for the treatment of obesity. The Company is based in Carmel, Indiana. To learn more, please visit the Company website at www.mbxbio.com and follow us on LinkedIn.

EEO Statement:

MBX Biosciences is an Equal Opportunity Employer and prohibits discrimination and harassment of any kind. MBX is committed to the principle of equal employment opportunity for all applicants and employees and to providing a work environment free of discrimination and harassment. All employment decisions are based on business needs, job requirements and individual qualifications, without regard to race, color, religion or belief, national, social or ethnic origin, sex (including pregnancy), age, physical, mental or sensory disability, HIV status, sexual orientation, gender identity and/or expression, marital, civil union or domestic partnership status, past or present military service, family medical history or genetic information, family or parental status, or any other status protected by the laws or regulations in the locations where we operate. We will not tolerate discrimination or harassment based on any of these characteristics. We encourage applicants of all ages.